BREAKING: FDA Pulls Valneva Chikungunya Vaccine From Market Over "Serious Safety Concerns"
by Nicolas Hulscher, MPH The FDA has just suspended approval of Valneva’s live-attenuated chikungunya vaccine Ixchiq, citing serious safety concerns—including 21 hospitalizations, 3 deaths, and confirmed cases of “chikungunya-like illness” triggered by the shot itself. The agency admitted the risks outweigh benefits “under most plausible scenarios.” On the surface, this looks like overdue regulatory accountability. […]
Discuss on Nostr!
Nostr Note ID note1eyn9twtkdu37vrks8pdk5l3hz2223hpwhx458vl8klt30lwvj48snc8x5y Open on Primal.net Open on Snort.social Open on Iris.to Open on Coracle.social
New to Nostr?
Create an account now & join the conversation!
Promote it on DissentWatch!
- To advertise this post for $0.02 per visit send bitcoins to the address below
- The post will be promoted daily via social media & our "Featured News" display in multiple places
- You can add more anytime
- Ranking order in the Featured News box is based on the balance remaining
Received: 0 mBTC (0.00 USD)
Spent: 0 mBTC (0.00 USD)
Balance: 0 mBTC (0.00 USD)
The amounts above may be lagging behind. If you just sent a payment click below to get more up to date results and push the post to the "Featured News" box faster.